{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:38Z","timestamp":1792783478503,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma Tor Vergata","id":[{"id":"https:\/\/ror.org\/02p77k626","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40266-026-01322-9","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:33:05Z","timestamp":1784529185000},"page":"755-772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bronchiectasis in Older Adults: Distinctive Epidemiology, Etiology, Diagnosis, and Clinical Evolution Compared with Younger Populations"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-9707","authenticated-orcid":false,"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"3","key":"1322_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/jama.2025.2680","volume":"334","author":"AF Barker","year":"2025","unstructured":"Barker AF, Karamooz E. Non-cystic fibrosis bronchiectasis in adults: a review. JAMA. 2025;334(3):253\u201364. https:\/\/doi.org\/10.1001\/jama.2025.2680.","journal-title":"JAMA"},{"issue":"6","key":"1322_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMra2202819","volume":"387","author":"AE O'Donnell","year":"2022","unstructured":"O\u2019Donnell AE. Bronchiectasis\u2014a clinical review. N Engl J Med. 2022;387(6):533\u201345. https:\/\/doi.org\/10.1056\/NEJMra2202819.","journal-title":"N Engl J Med"},{"issue":"174","key":"1322_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0091-2024","volume":"33","author":"M Nigro","year":"2024","unstructured":"Nigro M, Laska IF, Traversi L, Simonetta E, Polverino E. Epidemiology of bronchiectasis. Eur Respir Rev. 2024;33(174):240091. https:\/\/doi.org\/10.1183\/16000617.0091-2024.","journal-title":"Eur Respir Rev"},{"key":"1322_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/17534666251390073","volume":"19","author":"IF Laska","year":"2025","unstructured":"Laska IF. Prevalence of bronchiectasis: a narrative review. Ther Adv Respir Dis. 2025;19:17534666251390073. https:\/\/doi.org\/10.1177\/17534666251390073.","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"1322_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19956-y","volume":"24","author":"L Wang","year":"2024","unstructured":"Wang L, Wang J, Zhao G, Li J. Prevalence of bronchiectasis in adults: a meta-analysis. BMC Public Health. 2024;24(1):2675. https:\/\/doi.org\/10.1186\/s12889-024-19956-y.","journal-title":"BMC Public Health"},{"issue":"6","key":"1322_CR6","doi-asserted-by":"publisher","first-page":"1900499","DOI":"10.1183\/13993003.00499-2019","volume":"54","author":"FC Ringshausen","year":"2009","unstructured":"Ringshausen FC, Rademacher J, Pink I, et al. Increasing bronchiectasis prevalence in Germany, 2009-2017: a population-based cohort study. Eur Respir J. 2009;54(6):1900499. https:\/\/doi.org\/10.1183\/13993003.00499-2019.","journal-title":"Eur Respir J"},{"issue":"1","key":"1322_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-1050-0","volume":"20","author":"S Aliberti","year":"2020","unstructured":"Aliberti S, Sotgiu G, Lapi F, Gramegna A, Cricelli C, Blasi F. Prevalence and incidence of bronchiectasis in Italy. BMC Pulm Med. 2020;20(1):15. https:\/\/doi.org\/10.1186\/s12890-020-1050-0.","journal-title":"BMC Pulm Med"},{"key":"1322_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.rmed.2016.10.014","volume":"121","author":"M Monteagudo","year":"2016","unstructured":"Monteagudo M, Rodr\u00edguez-Blanco T, Barrecheguren M, Simonet P, Miravitlles M. Prevalence and incidence of bronchiectasis in Catalonia, Spain: a population-based study. Respir Med. 2016;121:26\u201331. https:\/\/doi.org\/10.1016\/j.rmed.2016.10.014.","journal-title":"Respir Med"},{"issue":"7","key":"1322_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","volume":"11","author":"JD Chalmers","year":"2023","unstructured":"Chalmers JD, Polverino E, Crichton ML, et al. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023;11(7):637\u201349. https:\/\/doi.org\/10.1016\/S2213-2600(23)00093-0.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"1322_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1183\/13993003.01033-2015","volume":"47","author":"JK Quint","year":"2016","unstructured":"Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J. 2016;47(1):186\u201393. https:\/\/doi.org\/10.1183\/13993003.01033-2015.","journal-title":"Eur Respir J"},{"key":"1322_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.rmed.2019.09.012","volume":"158","author":"N Snell","year":"2019","unstructured":"Snell N, Gibson J, Jarrold I, Quint JK. Epidemiology of bronchiectasis in the UK: findings from the British lung foundation\u2019s \u201cRespiratory health of the nation\u201d project. Respir Med. 2019;158:21\u20133. https:\/\/doi.org\/10.1016\/j.rmed.2019.09.012.","journal-title":"Respir Med"},{"issue":"6","key":"1322_CR12","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.chest.2018.07.014","volume":"154","author":"E Henkle","year":"2018","unstructured":"Henkle E, Chan B, Curtis JR, Aksamit TR, Daley CL, Winthrop KL. Characteristics and health-care utilization history of patients with bronchiectasis in US Medicare enrollees with prescription drug plans, 2006 to 2014. Chest. 2018;154(6):1311\u201320. https:\/\/doi.org\/10.1016\/j.chest.2018.07.014.","journal-title":"Chest"},{"issue":"1","key":"1322_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s41030-025-00328-9","volume":"12","author":"C Pendkar","year":"2026","unstructured":"Pendkar C, Ahluwalia AK. Nonpharmacologic care of bronchiectasis: addressing frailty with nutrition and physical activity. Pulm Ther. 2026;12(1):13\u201324. https:\/\/doi.org\/10.1007\/s41030-025-00328-9.","journal-title":"Pulm Ther"},{"issue":"Suppl. 1","key":"1322_CR14","doi-asserted-by":"publisher","first-page":"A1991","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A1991","volume":"211","author":"M El Labban","year":"2025","unstructured":"El Labban M, Al-Itelat A, Chalmers S, Kanj A. Frailty is associated with increased risk of 30-day readmission after bronchiectasis exacerbation. Am J Respir Crit Care Med. 2025;211(Suppl. 1):A1991. https:\/\/doi.org\/10.1164\/ajrccm.2025.211.Abstracts.A1991.","journal-title":"Am J Respir Crit Care Med"},{"key":"1322_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.rmed.2016.08.008","volume":"119","author":"G Bellelli","year":"2016","unstructured":"Bellelli G, Chalmers JD, Sotgiu G, et al. Characterization of bronchiectasis in the elderly. Respir Med. 2016;119:13\u20139. https:\/\/doi.org\/10.1016\/j.rmed.2016.08.008.","journal-title":"Respir Med"},{"key":"1322_CR16","doi-asserted-by":"publisher","first-page":"A1967","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A1967","volume":"211","author":"C Kato","year":"2025","unstructured":"Kato C, Ito Y, Mori Y, et al. Frailty and related factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2025;211:A1967. https:\/\/doi.org\/10.1164\/ajrccm.2025.211.Abstracts.A1967.","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"1322_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu17223574","volume":"17","author":"S \u0130ncedal Irgat","year":"2025","unstructured":"\u0130ncedal Irgat S, K\u0131z\u0131ltan G. Associations between frailty, sarcopenia, and nutritional status in older adults living in nursing homes. Nutrients. 2025;17(22):3574. https:\/\/doi.org\/10.3390\/nu17223574.","journal-title":"Nutrients"},{"key":"1322_CR18","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2147\/CIA.S143139","volume":"13","author":"TM Quinn","year":"2018","unstructured":"Quinn TM, Hill AT. Non-cystic fibrosis bronchiectasis in the elderly: current perspectives. Clin Interv Aging. 2018;13:1649\u201356. https:\/\/doi.org\/10.2147\/CIA.S143139.","journal-title":"Clin Interv Aging"},{"issue":"2","key":"1322_CR19","doi-asserted-by":"publisher","first-page":"2300442","DOI":"10.1183\/13993003.00442-2023","volume":"62","author":"CR Osadnik","year":"2023","unstructured":"Osadnik CR, Brighton LJ, Burtin C, et al. European Respiratory Society statement on frailty in adults with chronic lung disease. Eur Respir J. 2023;62(2):2300442. https:\/\/doi.org\/10.1183\/13993003.00442-2023.","journal-title":"Eur Respir J"},{"issue":"10150","key":"1322_CR20","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","volume":"392","author":"PA Flume","year":"2018","unstructured":"Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392(10150):880\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(18)31767-7.","journal-title":"Lancet"},{"issue":"6","key":"1322_CR21","doi-asserted-by":"publisher","first-page":"2501126","DOI":"10.1183\/13993003.01126-2025","volume":"66","author":"JD Chalmers","year":"2025","unstructured":"Chalmers JD, Haworth CS, Flume P, et al. European Respiratory Society clinical practice guideline for the management of adult bronchiectasis. Eur Respir J. 2025;66(6):2501126. https:\/\/doi.org\/10.1183\/13993003.01126-2025.","journal-title":"Eur Respir J"},{"issue":"10","key":"1322_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101456","volume":"12","author":"T Soma","year":"2022","unstructured":"Soma T, Nagata M. Immunosenescence, inflammaging, and lung senescence in asthma in the elderly. Biomolecules. 2022;12(10):1456. https:\/\/doi.org\/10.3390\/biom12101456.","journal-title":"Biomolecules"},{"key":"1322_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1006710","volume":"13","author":"BL Torrance","year":"2022","unstructured":"Torrance BL, Haynes L. Cellular senescence is a key mediator of lung aging and susceptibility to infection. Front Immunol. 2022;13:1006710. https:\/\/doi.org\/10.3389\/fimmu.2022.1006710.","journal-title":"Front Immunol"},{"issue":"4","key":"1322_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cger.2025.07.006","volume":"41","author":"LR Pollack","year":"2025","unstructured":"Pollack LR, Goss CH, Olivier KN. Considerations in the diagnosis and management of bronchiectasis in older adults. Clin Geriatr Med. 2025;41(4):539\u201351. https:\/\/doi.org\/10.1016\/j.cger.2025.07.006.","journal-title":"Clin Geriatr Med"},{"issue":"10150","key":"1322_CR25","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0140-6736(18)31554-X","volume":"392","author":"AB Chang","year":"2018","unstructured":"Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet. 2018;392(10150):866\u201379. https:\/\/doi.org\/10.1016\/S0140-6736(18)31554-X.","journal-title":"Lancet"},{"issue":"179","key":"1322_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0071-2025","volume":"35","author":"CMK Thomsen","year":"2026","unstructured":"Thomsen CMK, Kromann-Thomsen S, Thim S, Rubak S. Bronchiectasis in children: a systematic review of cytokine profile, immune cell phenotypes and microbiota in bronchoalveolar lavage fluid. Eur Respir Rev. 2026;35(179):250071. https:\/\/doi.org\/10.1183\/16000617.0071-2025.","journal-title":"Eur Respir Rev"},{"key":"1322_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/692546","volume":"2015","author":"MA Murray","year":"2015","unstructured":"Murray MA, Chotirmall SH. The impact of immunosenescence on pulmonary disease. Mediators Inflamm. 2015;2015:692546. https:\/\/doi.org\/10.1155\/2015\/692546.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"1322_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00653-20","volume":"89","author":"SR Simmons","year":"2021","unstructured":"Simmons SR, Bhalla M, Herring SE, Tchalla EYI, Bou Ghanem EN. Older but not wiser: the age-driven changes in neutrophil responses during pulmonary infections. Infect Immun. 2021;89(4):e00653-20. https:\/\/doi.org\/10.1128\/IAI.00653-20.","journal-title":"Infect Immun"},{"issue":"3","key":"1322_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.4049\/jimmunol.1700397","volume":"199","author":"CK Wong","year":"2017","unstructured":"Wong CK, Smith CA, Sakamoto K, Kaminski N, Koff JL, Goldstein DR. Aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice. J Immunol. 2017;199(3):1060\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1700397.","journal-title":"J Immunol"},{"issue":"9","key":"1322_CR30","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.4049\/jimmunol.1700140","volume":"199","author":"Z Li","year":"2017","unstructured":"Li Z, Jiao Y, Fan EK, et al. Aging-impaired filamentous actin polymerization signaling reduces alveolar macrophage phagocytosis of bacteria. J Immunol. 2017;199(9):3176\u201386. https:\/\/doi.org\/10.4049\/jimmunol.1700140.","journal-title":"J Immunol"},{"issue":"3","key":"1322_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70435","volume":"25","author":"MC Battaglia","year":"2026","unstructured":"Battaglia MC, Bhalla M, Marzullo B, et al. Host aging induces a senescent-like phenotype in neutrophils and altered transcriptional responses to Streptococcus pneumoniae. Aging Cell. 2026;25(3):e70435. https:\/\/doi.org\/10.1111\/acel.70435.","journal-title":"Aging Cell"},{"key":"1322_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102540","volume":"101","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady A, Pratico D, Tang D, Zhou S, Franceschi C, Ren J. Immunosenescence and inflammaging: mechanisms and role in diseases. Ageing Res Rev. 2024;101:102540. https:\/\/doi.org\/10.1016\/j.arr.2024.102540.","journal-title":"Ageing Res Rev"},{"key":"1322_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1704203","volume":"16","author":"E Karpuzoglu","year":"2025","unstructured":"Karpuzoglu E, Holladay SD, Gogal RM Jr. Inflammaging: triggers, molecular mechanisms, immunological consequences, sex differences, and cutaneous manifestations. Front Immunol. 2025;16:1704203. https:\/\/doi.org\/10.3389\/fimmu.2025.1704203.","journal-title":"Front Immunol"},{"key":"1322_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2026.178620","volume":"1016","author":"ME Juan","year":"2026","unstructured":"Juan ME, Verdaguer E, Prohens R, et al. Natural senotherapeutics in respiratory health: addressing cellular senescence, inflammaging, and immunosenescence in the aging lung. Eur J Pharmacol. 2026;1016:178620. https:\/\/doi.org\/10.1016\/j.ejphar.2026.178620.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1322_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/japplphysiol.00208.2016","volume":"123","author":"K Subramaniam","year":"2017","unstructured":"Subramaniam K, Kumar H, Tawhai MH. Evidence for age-dependent air-space enlargement contributing to loss of lung tissue elastic recoil pressure and increased shear modulus in older age. J Appl Physiol (1985). 2017;123(1):79\u201387. https:\/\/doi.org\/10.1152\/japplphysiol.00208.2016.","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"1322_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80108-8","volume":"14","author":"TE Corcoran","year":"2024","unstructured":"Corcoran TE, Broerman MJ, Kliment CR, Lo C. CFTR expression decreases with age in several airway cell types. Sci Rep. 2024;14(1):28832. https:\/\/doi.org\/10.1038\/s41598-024-80108-8.","journal-title":"Sci Rep"},{"issue":"5","key":"1322_CR37","doi-asserted-by":"publisher","first-page":"L882","DOI":"10.1152\/ajplung.00033.2018","volume":"315","author":"KL Bailey","year":"2018","unstructured":"Bailey KL, Kharbanda KK, Katafiasz DM, Sisson JH, Wyatt TA. Oxidative stress associated with aging activates protein kinase C\u03b5, leading to cilia slowing. Am J Physiol Lung Cell Mol Physiol. 2018;315(5):L882\u201390. https:\/\/doi.org\/10.1152\/ajplung.00033.2018.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"1322_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1473-3099(04)00931-4","volume":"4","author":"JP Janssens","year":"2004","unstructured":"Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis. 2004;4(2):112\u201324. https:\/\/doi.org\/10.1016\/S1473-3099(04)00931-4.","journal-title":"Lancet Infect Dis"},{"key":"1322_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/CIA.S97481","volume":"11","author":"R Wirth","year":"2016","unstructured":"Wirth R, Dziewas R, Beck AM, et al. Oropharyngeal dysphagia in older persons - from pathophysiology to adequate intervention: a review and summary of an international expert meeting. Clin Interv Aging. 2016;11:189\u2013208. https:\/\/doi.org\/10.2147\/CIA.S97481.","journal-title":"Clin Interv Aging"},{"issue":"4","key":"1322_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1055\/s-0041-1730891","volume":"42","author":"HR Keir","year":"2021","unstructured":"Keir HR, Chalmers JD. Pathophysiology of bronchiectasis. Semin Respir Crit Care Med. 2021;42(4):499\u2013512. https:\/\/doi.org\/10.1055\/s-0041-1730891.","journal-title":"Semin Respir Crit Care Med"},{"issue":"11","key":"1322_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-2600(24)00176-0","volume":"12","author":"MB Long","year":"2024","unstructured":"Long MB, Chotirmall SH, Shteinberg M, Chalmers JD. Rethinking bronchiectasis as an inflammatory disease. Lancet Respir Med. 2024;12(11):901\u201314. https:\/\/doi.org\/10.1016\/S2213-2600(24)00176-0.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"1322_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1183\/09031936.00212114","volume":"46","author":"LW Garratt","year":"2015","unstructured":"Garratt LW, Sutanto EN, Ling KM, et al. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis. Eur Respir J. 2015;46(2):384\u201394. https:\/\/doi.org\/10.1183\/09031936.00212114.","journal-title":"Eur Respir J"},{"issue":"4","key":"1322_CR43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.chest.2021.04.039","volume":"160","author":"L McGarvey","year":"2021","unstructured":"McGarvey L, Rubin BK, Ebihara S, et al. Global physiology and pathophysiology of cough: Part 2 Demographic and clinical considerations: CHEST expert panel report. Chest. 2021;160(4):1413\u201323. https:\/\/doi.org\/10.1016\/j.chest.2021.04.039.","journal-title":"Chest"},{"issue":"3","key":"1322_CR44","doi-asserted-by":"publisher","first-page":"1800328","DOI":"10.1183\/13993003.00328-2018","volume":"52","author":"E Polverino","year":"2018","unstructured":"Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018;52(3):1800328. https:\/\/doi.org\/10.1183\/13993003.00328-2018.","journal-title":"Eur Respir J"},{"key":"1322_CR45","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/COPD.S83910","volume":"10","author":"Y Ni","year":"2015","unstructured":"Ni Y, Shi G, Yu Y, Hao J, Chen T, Song H. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:1465\u201375. https:\/\/doi.org\/10.2147\/COPD.S83910.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"1322_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1164\/rccm.202309-1614OC","volume":"210","author":"E Polverino","year":"2024","unstructured":"Polverino E, De Soyza A, Dimakou K, et al. The association between bronchiectasis and chronic obstructive pulmonary disease: data from the European Bronchiectasis Registry (EMBARC). Am J Respir Crit Care Med. 2024;210(1):119\u201327. https:\/\/doi.org\/10.1164\/rccm.202309-1614OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1322_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150532","volume":"11","author":"Q Du","year":"2016","unstructured":"Du Q, Jin J, Liu X, Sun Y. Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS ONE. 2016;11(3):e0150532. https:\/\/doi.org\/10.1371\/journal.pone.0150532.","journal-title":"PLoS ONE"},{"issue":"1","key":"1322_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07772-6","volume":"12","author":"Y Kim","year":"2022","unstructured":"Kim Y, Kim K, Rhee CK, Ra SW. Increased hospitalizations and economic burden in COPD with bronchiectasis: a nationwide representative study. Sci Rep. 2022;12(1):3829. https:\/\/doi.org\/10.1038\/s41598-022-07772-6.","journal-title":"Sci Rep"},{"issue":"1","key":"1322_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12890-025-04011-2","volume":"26","author":"J Yoon","year":"2025","unstructured":"Yoon J, Yoon JH, Lee H, et al. Association between gastroesophageal reflux disease and incident bronchiectasis: a nationwide representative population-based study in Korea. BMC Pulm Med. 2025;26(1):7. https:\/\/doi.org\/10.1186\/s12890-025-04011-2.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"1322_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/nyas.14460","volume":"1482","author":"WW Chan","year":"2020","unstructured":"Chan WW, Ahuja N, Fisichella PM, Gavini S, Rangan V, Vela MF. Extraesophageal syndrome of gastroesophageal reflux: relationships with lung disease and transplantation outcome. Ann N Y Acad Sci. 2020;1482(1):95\u2013105. https:\/\/doi.org\/10.1111\/nyas.14460.","journal-title":"Ann N Y Acad Sci"},{"key":"1322_CR51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.rmed.2018.06.031","volume":"141","author":"MJ McDonnell","year":"2018","unstructured":"McDonnell MJ, O\u2019Toole D, Ward C, et al. A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: current understanding and future risk. Respir Med. 2018;141:132\u201343. https:\/\/doi.org\/10.1016\/j.rmed.2018.06.031.","journal-title":"Respir Med"},{"key":"1322_CR52","doi-asserted-by":"publisher","first-page":"175628482110628","DOI":"10.1177\/17562848211062801","volume":"14","author":"JH Yoon","year":"2021","unstructured":"Yoon JH, Kim SH, Ryu J, et al. Gastro-oesophageal reflux disease increases healthcare use and medical costs in patients with bronchiectasis: a Korean nationwide population-based study. Ther Adv Gastroenterol. 2021;14:17562848211062800. https:\/\/doi.org\/10.1177\/17562848211062801.","journal-title":"Ther Adv Gastroenterol"},{"issue":"2","key":"1322_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thoraxjnl-2015-208188","volume":"72","author":"V Navaratnam","year":"2017","unstructured":"Navaratnam V, Millett ER, Hurst JR, et al. Bronchiectasis and the risk of cardiovascular disease: a population-based study. Thorax. 2017;72(2):161\u20136. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-208188.","journal-title":"Thorax"},{"issue":"3","key":"1322_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.chest.2021.10.013","volume":"161","author":"R M\u00e9ndez","year":"2022","unstructured":"M\u00e9ndez R, Feced L, Alcaraz-Serrano V, et al. Cardiovascular events during and after bronchiectasis exacerbations and long-term mortality. Chest. 2022;161(3):629\u201336. https:\/\/doi.org\/10.1016\/j.chest.2021.10.013.","journal-title":"Chest"},{"issue":"1","key":"1322_CR55","doi-asserted-by":"publisher","first-page":"2500665","DOI":"10.1183\/13993003.00665-2025","volume":"67","author":"L Khalaili","year":"2026","unstructured":"Khalaili L, Aliberti S, Viligorska K, et al. Greater disease severity in adults with paediatric-onset versus adult-onset bronchiectasis: a multicentre EMBARC registry study. Eur Respir J. 2026;67(1):2500665. https:\/\/doi.org\/10.1183\/13993003.00665-2025.","journal-title":"Eur Respir J"},{"key":"1322_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rmed.2018.02.013","volume":"137","author":"O Sat\u0131rer","year":"2018","unstructured":"Sat\u0131rer O, Mete Yesil A, Emiralioglu N, et al. A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: a tertiary care experience. Respir Med. 2018;137:35\u20139. https:\/\/doi.org\/10.1016\/j.rmed.2018.02.013.","journal-title":"Respir Med"},{"issue":"3","key":"1322_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.rppnen.2017.08.009","volume":"24","author":"JC Costa","year":"2018","unstructured":"Costa JC, Machado JN, Ferreira C, Gama J, Rodrigues C. The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis. Pulmonology. 2018;24(3):149\u201354. https:\/\/doi.org\/10.1016\/j.rppnen.2017.08.009.","journal-title":"Pulmonology"},{"key":"1322_CR58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S121943","volume":"12","author":"MA Martinez-Garcia","year":"2017","unstructured":"Martinez-Garcia MA, Athanazio RA, Gir\u00f3n R, et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J Chron Obstruct Pulmon Dis. 2017;12:275\u201384. https:\/\/doi.org\/10.2147\/COPD.S121943.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"1322_CR59","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e16","volume":"35","author":"H Lee","year":"2020","unstructured":"Lee H, Lee E, Jang IY. Frailty and comprehensive geriatric assessment. J Korean Med Sci. 2020;35(3):e16. https:\/\/doi.org\/10.3346\/jkms.2020.35.e16.","journal-title":"J Korean Med Sci"},{"key":"1322_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101047","volume":"60","author":"A Pilotto","year":"2020","unstructured":"Pilotto A, Custodero C, Maggi S, Polidori MC, Veronese N, Ferrucci L. A multidimensional approach to frailty in older people. Ageing Res Rev. 2020;60:101047. https:\/\/doi.org\/10.1016\/j.arr.2020.101047.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"1322_CR61","doi-asserted-by":"publisher","first-page":"2100025","DOI":"10.1183\/13993003.00025-2021","volume":"58","author":"RH McLeese","year":"2021","unstructured":"McLeese RH, Spinou A, Alfahl Z, et al. Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis. Eur Respir J. 2021;58(5):2100025. https:\/\/doi.org\/10.1183\/13993003.00025-2021.","journal-title":"Eur Respir J"},{"issue":"5","key":"1322_CR62","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10096-016-2599-7","volume":"35","author":"S Izhakian","year":"2016","unstructured":"Izhakian S, Wasser WG, Fuks L, et al. Lobar distribution in non-cystic fibrosis bronchiectasis predicts bacteriologic pathogen treatment. Eur J Clin Microbiol Infect Dis. 2016;35(5):791\u20136. https:\/\/doi.org\/10.1007\/s10096-016-2599-7.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"1322_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-026-03553-1","volume":"27","author":"I Cadenas-Jim\u00e9nez","year":"2026","unstructured":"Cadenas-Jim\u00e9nez I, Camps-Massa P, Gon\u00e7alves-Carvalho F, et al. Epidemiological insights into Haemophilus influenzae and Pseudomonas aeruginosa persistent colonization in non-cystic fibrosis bronchiectasis patients: a longitudinal and multicenter study. Respir Res. 2026;27(1):87. https:\/\/doi.org\/10.1186\/s12931-026-03553-1.","journal-title":"Respir Res"},{"issue":"12","key":"1322_CR64","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s10096-019-03675-z","volume":"38","author":"A Pieters","year":"2019","unstructured":"Pieters A, Bakker M, Hoek RAS, et al. Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis. Eur J Clin Microbiol Infect Dis. 2019;38(12):2299\u2013304. https:\/\/doi.org\/10.1007\/s10096-019-03675-z.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"1322_CR65","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1056\/NEJM200103013440908","volume":"344","author":"PE Marik","year":"2001","unstructured":"Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344(9):665\u201371. https:\/\/doi.org\/10.1056\/NEJM200103013440908.","journal-title":"N Engl J Med"},{"key":"1322_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101235","volume":"66","author":"V Saint-Criq","year":"2021","unstructured":"Saint-Criq V, Lugo-Villarino G, Thomas M. Dysbiosis, malnutrition and enhanced gut-lung axis contribute to age-related respiratory diseases. Ageing Res Rev. 2021;66:101235. https:\/\/doi.org\/10.1016\/j.arr.2020.101235.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"1322_CR67","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/CCM.0000000000002253","volume":"45","author":"M Detsis","year":"2017","unstructured":"Detsis M, Karanika S, Mylonakis E. ICU acquisition rate, risk factors, and clinical significance of digestive tract colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis. Crit Care Med. 2017;45(4):705\u201314. https:\/\/doi.org\/10.1097\/CCM.0000000000002253.","journal-title":"Crit Care Med"},{"issue":"3","key":"1322_CR68","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MCP.0000000000000473","volume":"24","author":"MH Adelman","year":"2018","unstructured":"Adelman MH, Addrizzo-Harris DJ. Management of nontuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med. 2018;24(3):212\u20139. https:\/\/doi.org\/10.1097\/MCP.0000000000000473.","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"1322_CR69","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/s-0041-1730997","volume":"42","author":"S Tan","year":"2021","unstructured":"Tan S, Kasperbauer S. Nontuberculous mycobacteria. Semin Respir Crit Care Med. 2021;42(4):567\u201386. https:\/\/doi.org\/10.1055\/s-0041-1730997.","journal-title":"Semin Respir Crit Care Med"},{"key":"1322_CR70","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.2147\/IDR.S529466","volume":"18","author":"Y Feng","year":"2025","unstructured":"Feng Y, Guo J, Luo S, Zhang Z. Phenotyping nontuberculous mycobacterial lung disease: comparative analysis of clinical and imaging features in a TB-endemic setting. Infect Drug Resist. 2025;18:3527\u201334. https:\/\/doi.org\/10.2147\/IDR.S529466.","journal-title":"Infect Drug Resist."},{"issue":"1","key":"1322_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11010047","volume":"11","author":"C Hendrix","year":"2022","unstructured":"Hendrix C, McCrary M, Hou R, Abate G. Diagnosis and management of pulmonary NTM with a focus on Mycobacterium avium complex and Mycobacterium abscessus: challenges and prospects. Microorganisms. 2022;11(1):47. https:\/\/doi.org\/10.3390\/microorganisms11010047.","journal-title":"Microorganisms"},{"issue":"1","key":"1322_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02609-w","volume":"25","author":"C Sommer","year":"2024","unstructured":"Sommer C, Reamon-Buettner SM, Niehof M, et al. Age-dependent inflammatory response is altered in an ex vivo model of bacterial pneumonia. Respir Res. 2024;25(1):15. https:\/\/doi.org\/10.1186\/s12931-023-02609-w.","journal-title":"Respir Res"},{"issue":"6","key":"1322_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012733.pub2","volume":"6","author":"T Donovan","year":"2018","unstructured":"Donovan T, Felix LM, Chalmers JD, Milan SJ, Mathioudakis AG, Spencer S. Continuous versus intermittent antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018;6(6):CD012733. https:\/\/doi.org\/10.1002\/14651858.CD012733.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1322_CR74","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1714562","volume":"380","author":"LA Mandell","year":"2019","unstructured":"Mandell LA, Niederman MS. Aspiration pneumonia. N Engl J Med. 2019;380(7):651\u201363. https:\/\/doi.org\/10.1056\/NEJMra1714562.","journal-title":"N Engl J Med"},{"key":"1322_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106487","volume":"185","author":"R Shkeiri","year":"2021","unstructured":"Shkeiri R, Saliba W, Stein N, et al. Exploring factors associated with acquisition and chronicity of infection in bronchiectasis: a population-based study. Respir Med. 2021;185:106487. https:\/\/doi.org\/10.1016\/j.rmed.2021.106487.","journal-title":"Respir Med"},{"issue":"3","key":"1322_CR76","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1055\/a-2837-8778","volume":"47","author":"F Sartori","year":"2026","unstructured":"Sartori F, Crisafulli E, Cariqueo M, et al. Role of vaccination in the prevention of ECOPD. Semin Respir Crit Care Med. 2026;47(3):323\u201333. https:\/\/doi.org\/10.1055\/a-2837-8778.","journal-title":"Semin Respir Crit Care Med"},{"issue":"29","key":"1322_CR77","doi-asserted-by":"publisher","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","volume":"72","author":"M Melgar","year":"2023","unstructured":"Melgar M, Britton A, Roper LE, et al. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(29):793\u2013801. https:\/\/doi.org\/10.15585\/mmwr.mm7229a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1322_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/a-2586-3974","volume":"46","author":"T Bigoni","year":"2025","unstructured":"Bigoni T, Alfano F, Aloe F, et al. Respiratory syncytial virus prevention in the adult population: state of the art. Semin Respir Crit Care Med. 2025;46(1):41\u201352. https:\/\/doi.org\/10.1055\/a-2586-3974.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"1322_CR79","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/resp.13446","volume":"24","author":"KF O'Grady","year":"2019","unstructured":"O\u2019Grady KF, Cripps AW, Grimwood K. Paediatric and adult bronchiectasis: vaccination in prevention and management. Respirology. 2019;24(2):107\u201314. https:\/\/doi.org\/10.1111\/resp.13446.","journal-title":"Respirology"},{"issue":"10","key":"1322_CR80","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/bcp.14094","volume":"86","author":"AC Drenth-van Maanen","year":"2020","unstructured":"Drenth-van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people-how to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921\u201330. https:\/\/doi.org\/10.1111\/bcp.14094.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1322_CR81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40262-024-01466-0","volume":"64","author":"NN Ngcobo","year":"2025","unstructured":"Ngcobo NN. Influence of ageing on the pharmacodynamics and pharmacokinetics of chronically administered medicines in geriatric patients: a review. Clin Pharmacokinet. 2025;64(3):335\u201367. https:\/\/doi.org\/10.1007\/s40262-024-01466-0.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"1322_CR82","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s40266-023-01038-0","volume":"40","author":"MG Matera","year":"2023","unstructured":"Matera MG, Hanania NA, Maniscalco M, Cazzola M. Pharmacotherapies in plder adults with COPD: challenges and opportunities. Drugs Aging. 2023;40(7):605\u201319. https:\/\/doi.org\/10.1007\/s40266-023-01038-0.","journal-title":"Drugs Aging"},{"key":"1322_CR83","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.addr.2017.11.010","volume":"135","author":"M Wallin","year":"2018","unstructured":"Wallin M, Tagami T, Chen L, Yang M, Chan HK. Pulmonary drug delivery to older people. Adv Drug Deliv Rev. 2018;135:50\u201361. https:\/\/doi.org\/10.1016\/j.addr.2017.11.010.","journal-title":"Adv Drug Deliv Rev"},{"issue":"16","key":"1322_CR84","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJMoa2510095","volume":"393","author":"JM Bradley","year":"2025","unstructured":"Bradley JM, O\u2019Neill B, McAuley DF, et al. Hypertonic Saline or Carbocisteine in Bronchiectasis. N Engl J Med. 2025;393(16):1565\u201377. https:\/\/doi.org\/10.1056\/NEJMoa2510095.","journal-title":"N Engl J Med"},{"issue":"10","key":"1322_CR85","doi-asserted-by":"publisher","first-page":"9003","DOI":"10.21037\/jtd-2025-1159","volume":"17","author":"G Oscullo","year":"2025","unstructured":"Oscullo G, M\u00e9ndez R, Olveira C, et al. What is the optimal dose of N-acetylcysteine in adult patients with bronchiectasis?-data from the RIBRON registry. J Thorac Dis. 2025;17(10):9003\u201312. https:\/\/doi.org\/10.21037\/jtd-2025-1159.","journal-title":"J Thorac Dis"},{"issue":"1","key":"1322_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40265-021-01646-3","volume":"82","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2022","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, Oscullo G, Garc\u00eda-Ortega A, Matera MG, Rogliani P, Cazzola M. Rationale and clinical use of bronchodilators in adults with bronchiectasis. Drugs. 2022;82(1):1\u201313. https:\/\/doi.org\/10.1007\/s40265-021-01646-3.","journal-title":"Drugs"},{"issue":"14","key":"1322_CR87","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","volume":"82","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2022","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, Oscullo G, Garc\u00eda-Ortega A, Matera MG, Rogliani P, Cazzola M. Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: from bench to bedside. A narrative review. Drugs. 2022;82(14):1453\u201368. https:\/\/doi.org\/10.1007\/s40265-022-01785-1.","journal-title":"Drugs"},{"issue":"10","key":"1322_CR88","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","volume":"7","author":"JD Chalmers","year":"2019","unstructured":"Chalmers JD, Boersma W, Lonergan M, et al. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respir Med. 2019;7(10):845\u201354. https:\/\/doi.org\/10.1016\/S2213-2600(19)30191-2.","journal-title":"Lancet Respir Med"},{"key":"1322_CR89","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2147\/COPD.S181246","volume":"13","author":"Y Cui","year":"2018","unstructured":"Cui Y, Luo L, Li C, Chen P, Chen Y. Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:3813\u201329. https:\/\/doi.org\/10.2147\/COPD.S181246.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"1322_CR90","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","volume":"1","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases. Lancet Respir Med. 2013;1(3):262\u201374. https:\/\/doi.org\/10.1016\/S2213-2600(13)70038-9.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"1322_CR91","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00002018-199513020-00005","volume":"13","author":"NA von Rosensteil","year":"1995","unstructured":"von Rosensteil NA, Adam D. Macrolide antibacterials. Drug interactions of clinical significance. Drug Saf. 1995;13(2):105\u201322. https:\/\/doi.org\/10.2165\/00002018-199513020-00005.","journal-title":"Drug Saf"},{"key":"1322_CR92","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.01784-2025","author":"F Lavorini","year":"2026","unstructured":"Lavorini F, Sorano A, Fumagalli C, et al. Inhaler mastery and retention after stepwise training in cognitively impaired older COPD. ERJ Open Res. 2026. https:\/\/doi.org\/10.1183\/23120541.01784-2025.","journal-title":"ERJ Open Res"},{"issue":"5","key":"1322_CR93","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ejhpharm-2023-004075","volume":"32","author":"R A\u00f1ez-Casta\u00f1o","year":"2025","unstructured":"A\u00f1ez-Casta\u00f1o R, Iniesta-Naval\u00f3n C, Almanchel-Rivadeneyra M, Garc\u00eda-Villalba E, Oliver-Galera E, Rentero-Redondo L. Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease. Eur J Hosp Pharm. 2025;32(5):488\u201390. https:\/\/doi.org\/10.1136\/ejhpharm-2023-004075.","journal-title":"Eur J Hosp Pharm"},{"issue":"3","key":"1322_CR94","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2165\/11531490-000000000-00000","volume":"27","author":"R Stahlmann","year":"2010","unstructured":"Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging. 2010;27(3):193\u2013209. https:\/\/doi.org\/10.2165\/11531490-000000000-00000.","journal-title":"Drugs Aging"},{"issue":"16","key":"1322_CR95","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","volume":"392","author":"JD Chalmers","year":"2025","unstructured":"Chalmers JD, Burgel PR, Daley CL, et al. Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N Engl J Med. 2025;392(16):1569\u201381. https:\/\/doi.org\/10.1056\/NEJMoa2411664.","journal-title":"N Engl J Med"},{"issue":"1","key":"1322_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003862","volume":"19","author":"C McCarthy","year":"2022","unstructured":"McCarthy C, Clyne B, Boland F, et al. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): a cluster randomised controlled trial. PLoS Med. 2022;19(1):e1003862. https:\/\/doi.org\/10.1371\/journal.pmed.1003862.","journal-title":"PLoS Med"},{"issue":"4","key":"1322_CR97","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.70174","volume":"224","author":"HW Quek","year":"2026","unstructured":"Quek HW, Reus Perello X, Lee K, et al. Deprescribing in older people: a clinical practice guideline summary. Med J Aust. 2026;224(4):e70174. https:\/\/doi.org\/10.5694\/mja2.70174.","journal-title":"Med J Aust"},{"issue":"1","key":"1322_CR98","doi-asserted-by":"publisher","first-page":"1801264","DOI":"10.1183\/13993003.01264-2018","volume":"53","author":"S Patel","year":"2019","unstructured":"Patel S, Cole AD, Nolan CM, et al. Pulmonary rehabilitation in bronchiectasis: a propensity-matched study. Eur Respir J. 2019;53(1):1801264. https:\/\/doi.org\/10.1183\/13993003.01264-2018.","journal-title":"Eur Respir J"},{"issue":"4","key":"1322_CR99","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1164\/rccm.202306-1066ST","volume":"208","author":"CL Rochester","year":"2023","unstructured":"Rochester CL, Alison JA, Carlin B, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2023;208(4):e7\u201326. https:\/\/doi.org\/10.1164\/rccm.202306-1066ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"174","key":"1322_CR100","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0087-2024","volume":"33","author":"A Spinou","year":"2024","unstructured":"Spinou A, Lee AL, O\u2019Neil B, Oliveira A, Shteinberg M, Herrero-Cortina B. Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects. Eur Respir Rev. 2024;33(174):240087. https:\/\/doi.org\/10.1183\/16000617.0087-2024.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"1322_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86407-8","volume":"11","author":"H Choi","year":"2021","unstructured":"Choi H, Yang B, Kim YJ, et al. Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities. Sci Rep. 2021;11(1):7126. https:\/\/doi.org\/10.1038\/s41598-021-86407-8.","journal-title":"Sci Rep"},{"issue":"9","key":"1322_CR102","doi-asserted-by":"publisher","first-page":"967","DOI":"10.18553\/jmcp.2024.30.9.967","volume":"30","author":"J Tkacz","year":"2024","unstructured":"Tkacz J, Lewing B, Feliciano J, et al. Real-world treatment patterns, health care resource utilization, and costs in a US Medicare population with bronchiectasis. J Manag Care Spec Pharm. 2024;30(9):967\u201377. https:\/\/doi.org\/10.18553\/jmcp.2024.30.9.967.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"1322_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0818-6","volume":"19","author":"PC Goeminne","year":"2019","unstructured":"Goeminne PC, Hernandez F, Diel R, et al. The economic burden of bronchiectasis - known and unknown: a systematic review. BMC Pulm Med. 2019;19(1):54. https:\/\/doi.org\/10.1186\/s12890-019-0818-6.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"1322_CR104","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01269-2018","volume":"52","author":"R Boaventura","year":"2018","unstructured":"Boaventura R, Sibila O, Agusti A, Chalmers JD. Treatable traits in bronchiectasis. Eur Respir J. 2018;52(3):1801269. https:\/\/doi.org\/10.1183\/13993003.01269-2018.","journal-title":"Eur Respir J"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01322-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01322-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01322-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:10:40Z","timestamp":1789564240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01322-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":104,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01322-9","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Availability of data and materials","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prof. Mario Cazzola, Prof. Fabio Perrotta, Dr Raffaela Pagliaro, Dr Vincenzo Parente, and Prof. Maria Gabriella Matera declare that they do not have any conflict of interest that might be relevant to the content of this manuscript. Maria Gabriella Matera is an Editorial Board member of Drugs & Aging, but she was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MC and MGM supervised the project. All authors searched and screened all relevant literature. MC and MGM conducted the data extraction and collection. All authors performed the data analysis and review. MC and MGM drafted the manuscript. FP, RP, and VP critically revised the content. All authors read and approved the final version of the manuscript.","order":6,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}